RE-SEARCH study: dosing regimens with regorafenib in clinical practice in Spain: a retrospective study. 21749 (RESEARCH)
COMMERCIAL POST AUTHORIZATION STUDY
Clinical trial information
- Promoter: BAYER HISPANIA SL
- Execution start: 16/07/2021
- End of execution: 30/07/2022
- IP: ENCARNA GONZALEZ FLORES